Computationally driven discovery of phenyl(piperazin-1-yl)methanone derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors
Monoacylglycerol lipase (MAGL) is an attractive therapeutic target for many pathologies, including neurodegenerative diseases, cancer as well as chronic pain and inflammatory pathologies. The identification of reversible MAGL inhibitors, devoid of the side effects associated to prolonged MAGL inacti...
Saved in:
Main Authors: | Giulio Poli (Author), Margherita Lapillo (Author), Vibhu Jha (Author), Nayla Mouawad (Author), Isabella Caligiuri (Author), Marco Macchia (Author), Filippo Minutolo (Author), Flavio Rizzolio (Author), Tiziano Tuccinardi (Author), Carlotta Granchi (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors
by: Carlotta Granchi, et al.
Published: (2017) -
Binding investigation and preliminary optimisation of the 3-amino-1,2,4-triazin-5(2H)-one core for the development of new Fyn inhibitors
by: Giulio Poli, et al.
Published: (2018) -
Potential of Fatty Acid Amide Hydrolase (FAAH), Monoacylglycerol Lipase (MAGL), and Diacylglycerol Lipase (DAGL) Enzymes as Targets for Obesity Treatment: A Narrative Review
by: Justin Matheson, et al.
Published: (2021) -
[18F]MAGL-4-11 positron emission tomography molecular imaging of monoacylglycerol lipase changes in preclinical liver fibrosis models
by: Tuo Shao, et al.
Published: (2022) -
3D-QSAR study of benzotriazol-1-yl carboxamide scaffold as monoacylglycerol lipase inhibitors
by: Obaid Afzal, et al.
Published: (2014)